- Home
- PPSI vs VYNE Comparison
PPSI vs VYNE Comparison
Compare PPSI & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- VYNE
- Stock Information
- Founded
- PPSI 2008
- VYNE 2003
- Country
- PPSI United States
- VYNE United States
- Employees
- PPSI N/A
- VYNE N/A
- Industry
- PPSI Electrical Products
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- PPSI Industrials
- VYNE Health Care
- Exchange
- PPSI Nasdaq
- VYNE Nasdaq
- Market Cap
- PPSI 45.4M
- VYNE 41.9M
- IPO Year
- PPSI N/A
- VYNE 2018
- Fundamental
- Price
- PPSI $4.00
- VYNE $2.70
- Analyst Decision
- PPSI Strong Buy
- VYNE Strong Buy
- Analyst Count
- PPSI 2
- VYNE 2
- Target Price
- PPSI $10.50
- VYNE $6.88
- AVG Volume (30 Days)
- PPSI 89.7K
- VYNE 153.7K
- Earning Date
- PPSI 11-14-2024
- VYNE 02-27-2025
- Dividend Yield
- PPSI N/A
- VYNE N/A
- EPS Growth
- PPSI N/A
- VYNE N/A
- EPS
- PPSI N/A
- VYNE N/A
- Revenue
- PPSI $34,043,000.00
- VYNE $493,000.00
- Revenue This Year
- PPSI $8.45
- VYNE $28.30
- Revenue Next Year
- PPSI $16.50
- VYNE N/A
- P/E Ratio
- PPSI N/A
- VYNE N/A
- Revenue Growth
- PPSI N/A
- VYNE 39.27
- 52 Week Low
- PPSI $3.35
- VYNE $1.57
- 52 Week High
- PPSI $7.00
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- PPSI 32.63
- VYNE 43.45
- Support Level
- PPSI $3.90
- VYNE $2.57
- Resistance Level
- PPSI $4.07
- VYNE $4.30
- Average True Range (ATR)
- PPSI 0.19
- VYNE 0.39
- MACD
- PPSI 0.05
- VYNE -0.11
- Stochastic Oscillator
- PPSI 18.87
- VYNE 7.51
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc manufactures, sells, and services a broad range of specialty electrical transmission, distribution, and on-site power generation equipment for applications in the utility, industrial, commercial and backup power markets. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets. Pioneer Power works in two reportable segments which includes Electrical Infrastructure Equipment and Critical Power Solutions (Critical Power). Pioneer generates the majority of its revenue from the United States of America.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.